EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
EFTR
Delisted
EFTR was delisted on the 2nd of July, 2024.
25 hedge funds and large institutions have $5.49M invested in eFFECTOR Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
25
Holding in Top 10
–
Calls
$5.46M
Puts
–
Top Buyers
| 1 | +$79.6K | |
| 2 | +$67.4K | |
| 3 | +$58K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$46.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$28.8K |
Top Sellers
| 1 | -$4.03M | |
| 2 | -$2.42M | |
| 3 | -$158K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$29.6K |
| 5 |
EWA
EP Wealth Advisors
Torrance,
California
|
-$18.6K |